Year of Publication
Doctor of Nursing Practice
Dr. Leslie Scott
Dr. Dianna Inman
According to the CDC, about 79 million Americans are currently infected with Human papillomavirus (HPV) with an additional 14 million infected annually, most of which are teenagers and young adults. Of these 14 million newly diagnosed cases, approximately 27,000 are diagnosed with a cancer caused by HPV. Kentucky’s HPV vaccination initiation and completion rates are below national estimates.
In 2013, Kentucky’s vaccine completion rate for girls age 13 to 17 was 26.8 percent compared to United States completion rate of 37.6 percent. Kentucky vaccine completion rate for boys age 13 to 17 was 19 percent compared to a United States completion rate of 35 percent.
It is estimated that for every 5 year delay of vaccinating against HPV will yield in 1.5 to 2 million new cases of cervical cancer each year. There are three vaccines licensed by the FDA; Cervarix, Gardasil and Gardasil 9. These are all to be given in a 3-dose series with doses given at 0, 1-2 and 6 months. It is imperative that primary care providers advocate for the recommended administration of the HPV vaccine and disseminate factual and up-to-date information to parents and caregivers.
Wilson, Madeline A., "Evaluating Provider Knowledge of the HPV Vaccine in Kentucky" (2016). DNP Projects. 94.